iBio (IBIO) Change in Accrued Expenses (2009 - 2026)
iBio (IBIO) reported Change in Accured Expenses of $2.82 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$54,000 a year earlier and up 579.0% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Change in Accrued Expenses (2009 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio posted Change in Accured Expenses of $3.11 million.
- Change in Accured Expenses has a five-year compound annual growth rate of 10.4% (FY2021 to FY2026).
- By fiscal year, Change in Accured Expenses came in at -$758,000 in FY2025, -$1.73 million in FY2024, $145,000 in FY2023 (-90.0%) and $1.44 million in FY2022 (-23.9%).
- The fiscal Q4 2026 figure ranks as the highest quarterly Change in Accured Expenses in data going back to fiscal Q1 2011.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $415,000 (Q3 2026), $567,000 (Q2 2026) and -$686,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - | -1.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1.04 Mn |
| Jun 30, 2026 | 2.82 Mn |
| Mar 31, 2026 | 415,000.00 |
| Dec 31, 2025 | 567,000.00 |
| Sep 30, 2025 | -686,000.00 |
| Jun 30, 2025 | -54,000.00 |
| Mar 31, 2025 | 240,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | -952,000.00 |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | 385,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | -874,000.00 |
| Jun 30, 2023 | 163,000.00 |
| Mar 31, 2023 | -1.26 Mn |
| Dec 31, 2022 | 2.41 Mn |
| Sep 30, 2022 | -1.17 Mn |
| Jun 30, 2022 | 825,000.00 |
| Mar 31, 2022 | 96,000.00 |
| Dec 31, 2021 | 791,000.00 |
API Access
iBio Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();